1)Schrag SJ, Zywicki S, Farley MM, et al:Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342:15-20,2000
2)Jordan HT, Farley MM, Craig A, et al:Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 27:1057-1064,2008
3)Verani JR, McGee L, Schrag SJ, et al:Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep 59(RR-10):1-36,2010
4)Kimura K, Suzuki S, Wachino J, et al:First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890-2897,2008
5)Nagano N, Nagano Y, Kimura K, et al:Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:4258-4267,2008
6)Nagano N, Nagano Y, Toyama M, et al:Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J Antimicrob Chemother 67:849-856,2012